New hope for Tough-to-Treat lung cancer? drug trial targets specific mutation

This study tested whether a drug called daratumumab, given as an injection under the skin, could help control advanced lung cancer that has a specific genetic change (STK11 mutation) and has stopped responding to standard treatments. Eight patients who had already tried chemotherapy and immunotherapy received the drug on a regular schedule to see if their tumors would shrink. The main goal was to see if this approach showed enough promise to warrant larger studies.